<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药明康德 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-30T11:34:14+08:00</updated>
  <subtitle>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药明康德“DELopen新药筛选包”项目获得第五届 “社会价值共创”优秀奖</title>
    <updated>2020-11-30T07:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/N8b4bRTKFCqrmhOxSqZdKQ</id>
    <link href="https://mp.weixin.qq.com/s/N8b4bRTKFCqrmhOxSqZdKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 31亿美元开发突破性抑郁症和运动障碍疗法，渤健达成研发合作</title>
    <updated>2020-11-30T07:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/_e0pgUy7Ts2_q7KUO2uYng</id>
    <link href="https://mp.weixin.qq.com/s/_e0pgUy7Ts2_q7KUO2uYng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准三年里第三款RNAi药物;BMS与Schrödinger达成近28亿美元合作</title>
    <updated>2020-11-30T07:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/U00c4fwgeIJnaB9_gJWtTw</id>
    <link href="https://mp.weixin.qq.com/s/U00c4fwgeIJnaB9_gJWtTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 首个治疗特定基因缺陷引起的肥胖症新药获FDA批准</title>
    <updated>2020-11-30T07:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/G_yToiyRla-PmmwL8mP_Og</id>
    <link href="https://mp.weixin.qq.com/s/G_yToiyRla-PmmwL8mP_Og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>孤儿药周报 | 杨森BCMA双特异性抗体、基因泰克反义寡核苷酸疗法等创新疗法入围</title>
    <updated>2020-11-30T07:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/V_OutcDjk27cpqZTEqpLRQ</id>
    <link href="https://mp.weixin.qq.com/s/V_OutcDjk27cpqZTEqpLRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明晚8点！病理学家如何推动医疗器械研发加速</title>
    <updated>2020-11-30T07:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/18bpfmCpumq9_EyCLlU5aw</id>
    <link href="https://mp.weixin.qq.com/s/18bpfmCpumq9_EyCLlU5aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>联合PD-1/PD-L1疗法，哪些靶点受到关注？</title>
    <updated>2020-11-26T23:37:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Acg3NIVDiXSzoNR-SP1n9Q</id>
    <link href="https://mp.weixin.qq.com/s/Acg3NIVDiXSzoNR-SP1n9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罕见病专栏 | 一周罕闻药事（11.21-11.26）</title>
    <updated>2020-11-26T23:37:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/5pO9Ema31emmQZPvTdEMnQ</id>
    <link href="https://mp.weixin.qq.com/s/5pO9Ema31emmQZPvTdEMnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>喜讯！FDA加速批准Danyelza单抗用于治疗复发/难治性神经母细胞瘤</title>
    <updated>2020-11-26T23:37:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/JpTEBMGnyzIrGNYUT8v_Qg</id>
    <link href="https://mp.weixin.qq.com/s/JpTEBMGnyzIrGNYUT8v_Qg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 干细胞治疗新冠相关呼吸疾病，诺华达成13.5亿美元协议</title>
    <updated>2020-11-26T23:37:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/KUSEVjV8rDYDOYo6lCApNw</id>
    <link href="https://mp.weixin.qq.com/s/KUSEVjV8rDYDOYo6lCApNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“社交隔离”…你知道这让大脑多难受吗？MIT新研究表明，和饿肚子一样！</title>
    <updated>2020-11-26T23:37:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/YEWNf0-F7sDVO4fghXgo8g</id>
    <link href="https://mp.weixin.qq.com/s/YEWNf0-F7sDVO4fghXgo8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗取得积极结果后，还有哪些问题值得留意？</title>
    <updated>2020-11-26T07:23:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/ODMrnzIrvtFyu8PyFjIbYQ</id>
    <link href="https://mp.weixin.qq.com/s/ODMrnzIrvtFyu8PyFjIbYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 靶向p53突变，潜在新药启动临床试验</title>
    <updated>2020-11-26T07:23:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/lwLPYzXG9TZ_O_mUGa1ExA</id>
    <link href="https://mp.weixin.qq.com/s/lwLPYzXG9TZ_O_mUGa1ExA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多款新冠疫苗保护力超90%，为什么还需要继续同时研发上百种疫苗？</title>
    <updated>2020-11-26T07:23:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/FAjGV9QwYnFGzRhZ3ty2EA</id>
    <link href="https://mp.weixin.qq.com/s/FAjGV9QwYnFGzRhZ3ty2EA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRISPR抗癌突破！《科学》子刊发表首个动物实验结果，生存率可提高80%</title>
    <updated>2020-11-26T07:23:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/PbvTbp60hd_1aIQpa8eQWw</id>
    <link href="https://mp.weixin.qq.com/s/PbvTbp60hd_1aIQpa8eQWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华公布最新研发管线：哪些在研新药值得关注？（附PDF）</title>
    <updated>2020-11-25T13:48:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/6ctsX1Q9UbhLyjvt3wUvDw</id>
    <link href="https://mp.weixin.qq.com/s/6ctsX1Q9UbhLyjvt3wUvDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA批准三年里第三款RNAi药物</title>
    <updated>2020-11-25T13:48:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/x6-wkUaabiWdgGWkTlL5ZQ</id>
    <link href="https://mp.weixin.qq.com/s/x6-wkUaabiWdgGWkTlL5ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>暴露后预防！罗氏流感新药Xofluza获FDA批准新适应症</title>
    <updated>2020-11-25T13:48:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/HIzGEvl37nE9aoCnYrpA2Q</id>
    <link href="https://mp.weixin.qq.com/s/HIzGEvl37nE9aoCnYrpA2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明日下午3点！创新药中美双报CMC策略分享</title>
    <updated>2020-11-25T13:48:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/5hmyigbICKDoxxS6R8Czsg</id>
    <link href="https://mp.weixin.qq.com/s/5hmyigbICKDoxxS6R8Czsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注！TCR疗法喜迎首个积极3期结果，显著提高总生存率</title>
    <updated>2020-11-24T07:54:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/gYkKpa6W7Yp193uL9HB1zA</id>
    <link href="https://mp.weixin.qq.com/s/gYkKpa6W7Yp193uL9HB1zA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>